ATE335475T1 - Verwendung von beschleunigten lymphozyten zielansteuernden wirkstoffen zur herstellung eines medikaments für die behandlung der verzögertern transplantat-funktion - Google Patents
Verwendung von beschleunigten lymphozyten zielansteuernden wirkstoffen zur herstellung eines medikaments für die behandlung der verzögertern transplantat-funktionInfo
- Publication number
- ATE335475T1 ATE335475T1 AT02711877T AT02711877T ATE335475T1 AT E335475 T1 ATE335475 T1 AT E335475T1 AT 02711877 T AT02711877 T AT 02711877T AT 02711877 T AT02711877 T AT 02711877T AT E335475 T1 ATE335475 T1 AT E335475T1
- Authority
- AT
- Austria
- Prior art keywords
- medication
- producing
- treatment
- targeting agents
- transplant function
- Prior art date
Links
- 239000003795 chemical substances by application Substances 0.000 title abstract 2
- 210000004698 lymphocyte Anatomy 0.000 title abstract 2
- 230000003111 delayed effect Effects 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 230000008685 targeting Effects 0.000 title 1
- KJJPLEZQSCZCKE-UHFFFAOYSA-N 2-aminopropane-1,3-diol Chemical class OCC(N)CO KJJPLEZQSCZCKE-UHFFFAOYSA-N 0.000 abstract 1
- 208000021709 Delayed Graft Function Diseases 0.000 abstract 1
- 210000000056 organ Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/133—Amines having hydroxy groups, e.g. sphingosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/131—Amines acyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0104438A GB0104438D0 (en) | 2001-02-22 | 2001-02-22 | Organic compounds |
| GB0105000A GB0105000D0 (en) | 2001-02-28 | 2001-02-28 | Organic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE335475T1 true ATE335475T1 (de) | 2006-09-15 |
Family
ID=26245749
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02711877T ATE335475T1 (de) | 2001-02-22 | 2002-02-21 | Verwendung von beschleunigten lymphozyten zielansteuernden wirkstoffen zur herstellung eines medikaments für die behandlung der verzögertern transplantat-funktion |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20040087662A1 (enExample) |
| EP (1) | EP1368015B1 (enExample) |
| JP (1) | JP4318921B2 (enExample) |
| CN (1) | CN100479814C (enExample) |
| AT (1) | ATE335475T1 (enExample) |
| BR (1) | BR0207434A (enExample) |
| CA (1) | CA2435739A1 (enExample) |
| DE (1) | DE60213766T2 (enExample) |
| ES (1) | ES2267993T3 (enExample) |
| PT (1) | PT1368015E (enExample) |
| WO (1) | WO2002067915A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL364359A1 (en) * | 2001-06-08 | 2004-12-13 | Novartis Ag | Treatment or prophylaxis of insulin-producing cell graft rejection |
| ATE435202T1 (de) | 2002-01-11 | 2009-07-15 | Daiichi Sankyo Co Ltd | Aminoalkoholderivat oder phosphonsäurederivat und diese enthaltende medizinische zusammensetzung |
| CN1921847B (zh) | 2004-02-24 | 2010-06-16 | 三共株式会社 | 氨基醇化合物 |
| SI1772145T1 (sl) * | 2004-07-16 | 2011-06-30 | Kyorin Seiyaku Kk | Postopek za učinkovito uporabo zdravila in postopek za preprečevanje stranskih učinkov |
| PT2511262T (pt) * | 2004-10-12 | 2017-03-30 | Kyorin Seiyaku Kk | Processo para a produção de cloridrato de 2-amino-2-[2-[4-(3- benziloxi-feniltio)-2-clorofenil[etil]-1,3-propanodiol |
| WO2007043433A1 (ja) * | 2005-10-07 | 2007-04-19 | Kyorin Pharmaceutical Co., Ltd. | ２－アミノ－１，３－プロパンジオール誘導体を有効成分とする肝臓疾患治療剤および肝臓疾患治療方法 |
| TWI389683B (zh) * | 2006-02-06 | 2013-03-21 | Kyorin Seiyaku Kk | A therapeutic agent for an inflammatory bowel disease or an inflammatory bowel disease treatment using a 2-amino-1,3-propanediol derivative as an active ingredient |
| SG174028A1 (en) * | 2006-08-08 | 2011-09-29 | Kyorin Seiyaku Kk | Aminophosphoric acid ester derivative and s1p receptor modulator containing the same as active ingredient |
| SG174029A1 (en) * | 2006-08-08 | 2011-09-29 | Kyorin Seiyaku Kk | Aminoalcohol derivative and immunosuppressant containing the same as active ingredient |
| JP5452237B2 (ja) | 2008-02-07 | 2014-03-26 | 杏林製薬株式会社 | アミノアルコール誘導体を有効成分とする炎症性腸疾患の治療剤又は予防剤 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3928572A (en) * | 1971-02-11 | 1975-12-23 | Ayerst Mckenna & Harrison | Myriocin and process of preparation |
| DK0627406T3 (da) * | 1992-10-21 | 1999-07-12 | Taito Co | 2-Amino-1,3-propandiolforbindelser og immunundertrykkende midler |
| RU2156127C2 (ru) * | 1995-12-28 | 2000-09-20 | Еситоми Фармасьютикал Индустриз, Лтд. | Препарат местного применения для иммуносупрессии и лечения аутоиммунных или аллергических заболеваний |
| GB9624038D0 (en) * | 1996-11-19 | 1997-01-08 | Sandoz Ltd | Organic compounds |
| DK1319651T3 (da) * | 1997-04-04 | 2005-08-01 | Mitsubishi Pharma Corp | 2-aminopropan-1,3-diolforbindelser, medicinsk anvendelse deraf og mellemprodukter til syntese af disse |
| JPH1180026A (ja) * | 1997-09-02 | 1999-03-23 | Yoshitomi Pharmaceut Ind Ltd | 新規免疫抑制剤、その使用方法およびその同定方法 |
| PL364359A1 (en) * | 2001-06-08 | 2004-12-13 | Novartis Ag | Treatment or prophylaxis of insulin-producing cell graft rejection |
-
2002
- 2002-02-21 JP JP2002567283A patent/JP4318921B2/ja not_active Expired - Fee Related
- 2002-02-21 CN CNB028053958A patent/CN100479814C/zh not_active Expired - Fee Related
- 2002-02-21 WO PCT/EP2002/001860 patent/WO2002067915A1/en not_active Ceased
- 2002-02-21 EP EP02711877A patent/EP1368015B1/en not_active Expired - Lifetime
- 2002-02-21 ES ES02711877T patent/ES2267993T3/es not_active Expired - Lifetime
- 2002-02-21 AT AT02711877T patent/ATE335475T1/de not_active IP Right Cessation
- 2002-02-21 CA CA002435739A patent/CA2435739A1/en not_active Abandoned
- 2002-02-21 DE DE60213766T patent/DE60213766T2/de not_active Expired - Fee Related
- 2002-02-21 BR BR0207434-6A patent/BR0207434A/pt not_active IP Right Cessation
- 2002-02-21 PT PT02711877T patent/PT1368015E/pt unknown
- 2002-02-21 US US10/468,471 patent/US20040087662A1/en not_active Abandoned
-
2007
- 2007-09-26 US US11/861,586 patent/US20080015261A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN100479814C (zh) | 2009-04-22 |
| HK1060855A1 (en) | 2004-08-27 |
| CA2435739A1 (en) | 2002-09-06 |
| DE60213766D1 (de) | 2006-09-21 |
| DE60213766T2 (de) | 2007-08-02 |
| BR0207434A (pt) | 2004-07-06 |
| CN1492757A (zh) | 2004-04-28 |
| ES2267993T3 (es) | 2007-03-16 |
| JP4318921B2 (ja) | 2009-08-26 |
| EP1368015B1 (en) | 2006-08-09 |
| JP2004527490A (ja) | 2004-09-09 |
| US20080015261A1 (en) | 2008-01-17 |
| US20040087662A1 (en) | 2004-05-06 |
| WO2002067915A1 (en) | 2002-09-06 |
| PT1368015E (pt) | 2006-12-29 |
| EP1368015A1 (en) | 2003-12-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO5700767A2 (es) | Procedimiento de tratamiento de rechazo de transplantes | |
| CO5221115A1 (es) | Nuevos compuestos fungicidas | |
| MX336500B (es) | Insecticida para uso agricola u horticola y metodo para su uso. | |
| CY1116107T1 (el) | Ενωσεις για χρηση στην αγωγη αυτοανοσων παθησεων, ανοσο-αλλεργικων παθησεων και απορριψης μεταμοσχευσης οργανων ή ιστων | |
| TW200714283A (en) | Method and composition for treating peripheral vascular diseases | |
| DE69937888D1 (de) | Verbesserung der herzfunktion durch transplantation mesenchymaler stammzellen | |
| WO2004039248A3 (en) | Repairing or replacing tissues or organs | |
| ATE539701T1 (de) | Zusammengesetzte schlinge zur behandlung von inkontinenz | |
| ATE322681T1 (de) | Inhibitoren für wachstumdifferenzierungsfaktor und ihre anwendungen | |
| ATE526991T1 (de) | Zusammensetzungen und ihre verwendungen für die gentherapeutische behandlung von knochenerkrankungen | |
| EA200802213A1 (ru) | Способы лечения заболеваний крови | |
| DE60043229D1 (de) | Zusammensetzung zur gefässbeschichtung | |
| ATE404229T1 (de) | Körper zum erzeugen von knochenwachstum und/oder bindegewebe und verfahren zur herstellung solches körpers | |
| ATE414089T1 (de) | Verwendung von rapamycin und dessen derivaten zur behandlung von knochenverlust | |
| UA88463C2 (ru) | Фармацевтическая композиция, которая содержит соединение 1, и процесс лечения вич-инфекции | |
| ES2530872T3 (es) | Organos y células modificados para xenotrasplante | |
| ATE335475T1 (de) | Verwendung von beschleunigten lymphozyten zielansteuernden wirkstoffen zur herstellung eines medikaments für die behandlung der verzögertern transplantat-funktion | |
| ATE217889T1 (de) | Humane antikörper gegen faktor ix/ixa | |
| DE602005026866D1 (de) | Vewendung von dreidimensionalem kultiviertem gewebe zur behandlung von kongestivem herzversagen | |
| ATE417921T1 (de) | Herstellung von tacrolimus (fk-506) unter verwendung neuer streptomyces-spezies | |
| DK1178726T3 (da) | Vandig opløsning til konservering af væv og organer | |
| BR0316245A (pt) | Atividade antimicrobiana de espécie de oxigênio reativo produtora de anticorpos | |
| DE69930419D1 (de) | Verwendung von menschliche protein c zur herstellung eines arzneimittels zur behandlung von heparininduzierter thrombozytopenie | |
| GB0029410D0 (en) | Embalming fluid | |
| DE60007991D1 (de) | Verwendung des proteins uk 114 zur verhinderung der abstossung eines transplantierten organs |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1368015 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |